Table 2.
Comparison of baseline demographic and clinical characteristics between ischaemic stroke and no stroke HIV + ve patients
| Characteristics | Ischaemic stroke HIV + ve N = 52 |
No stroke HIV + ve N = 52 |
P - value |
|---|---|---|---|
| Age, years, mean(Std. Dev.) | 52 (13.0) | 46 (11.8) | 0.014 a |
| Sex, female, n(%) | 29 (56) | 29 (56) | 0.999 |
| Hypertension, n(%) | 26 (50) | 9 (17) | <0.001 a |
| Diabetes mellitus, n(%) | 8 (15) | 3 (6) | 0.111 |
| Alcohol, n(%) | 10 (19) | 4 (8) | 0.085 |
| Smoking, n(%) | 2 (4) | 2 (4) | 0.999 |
| ART use(current & previous), n(%) | 36 (69) | 46 (88) | 0.016 a |
| NRTI use, n(%) | 34 (65) | 49 (94) | 0.999 |
| NNRTI use, n(%) | 33 (63) | 46 (88) | 0.641 |
| PI use, n(%) | 1 (2) | 3 (6) | 0.644 |
| ART duration(>3 months), n(%) | 47 (90) | 51 (94) | 0.205 |
| Hypercholesterolaemia > 5.2 mmol/l | 4 (8) | 4 (8) | 0.999 |
| Serum creatinine(>120umol/l),n(%) | 6 (12) | 4 (8) | 0.322 |
| Hb, g/dl (range) | 12.6 (10.5 – 14.6) | 12.2 (9.7 – 14.7) | 0.470 |
| CD4 count, cells/ul (range) | 431 (111 – 751) | 422 (164 – 680) | 0.885 |
astatistically significant